Pricing Log in Create free account

Immunic, Inc. (IMUX) vs PolyPid Ltd. (PYPD)

Immunic, Inc. and PolyPid Ltd. are both Biotechnology companies. Immunic, Inc. and PolyPid Ltd. are of similar size ($99.5M and $96.9M). Across the 8 metrics below, Immunic, Inc. leads on 6 and PolyPid Ltd. on 2.

Valuation

Metric IMUX PYPD Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.32 19.96 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (62.84%) (31.16%) (33.15%)
Free cash flow yield (29.71%) (71.51%) (25.50%)

Profitability

Metric IMUX PYPD Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.17%) (243.59%) (56.36%)
Return on assets (101.15%) (119.05%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMUX PYPD Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 38.00% 57.43% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMUX PYPD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.05 1.35 4.72
Net debt to EBITDA 0.15 0.39 0.96

Dividend

Metric IMUX PYPD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMUX PYPD Biotechnology median
Market cap 96.87m 99.53m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack